SELECT-LIFE (SELECT follow-up study to evaluate Longterm Impact oF anti-obEsity medication) - Trial 2021-003306-42

Name: Clinical Trial 2021-003306-42
Creator: Novo Nordisk A/S
Keywords: Obesity, clinical trial

Access comprehensive clinical trial information for 2021-003306-42 through Pure Global AI's free database. This phase not specified trial is sponsored by Novo Nordisk A/S and is currently status unknown. The study focuses on Obesity.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

2021-003306-42

Trial Details

EU Clinical Trials Register • 2021-003306-42

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

SELECT-LIFE (SELECT follow-up study to evaluate Longterm Impact oF anti-obEsity medication)

Study Focus

Disease/Condition

Obesity

Sponsor & Location

Primary Sponsor

Novo Nordisk A/S

Timeline & Enrollment

Phase

N/A

Start Date

N/A

End Date

N/A

ICD-10 Classifications

Obesity

Other obesity

Obesity, unspecified

Obesity due to excess calories

Obesity and other hyperalimentation

Data Source

Registry

EU Clinical Trials Register

Trial ID

2021-003306-42

Type

Non-Device Trial